Eton Pharmaceuticals (ETON) Shares Outstanding (Weighted Average) (2019 - 2025)
Historic Shares Outstanding (Weighted Average) for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to $26.9 million.
- Eton Pharmaceuticals' Shares Outstanding (Weighted Average) rose 383.4% to $26.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.9 million, marking a year-over-year increase of 383.4%. This contributed to the annual value of $25.9 million for FY2024, which is 97.37% up from last year.
- According to the latest figures from Q3 2025, Eton Pharmaceuticals' Shares Outstanding (Weighted Average) is $26.9 million, which was up 383.4% from $26.9 million recorded in Q2 2025.
- In the past 5 years, Eton Pharmaceuticals' Shares Outstanding (Weighted Average) ranged from a high of $26.9 million in Q2 2025 and a low of $25211.0 during Q2 2021
- Its 5-year average for Shares Outstanding (Weighted Average) is $20.3 million, with a median of $25.3 million in 2022.
- In the last 5 years, Eton Pharmaceuticals' Shares Outstanding (Weighted Average) plummeted by 9989.91% in 2023 and then surged by 10083373.95% in 2024.
- Over the past 5 years, Eton Pharmaceuticals' Shares Outstanding (Weighted Average) (Quarter) stood at $25.2 million in 2021, then fell by 0.24% to $25.1 million in 2022, then grew by 1.99% to $25.6 million in 2023, then grew by 0.97% to $25.9 million in 2024, then rose by 3.85% to $26.9 million in 2025.
- Its Shares Outstanding (Weighted Average) was $26.9 million in Q3 2025, compared to $26.9 million in Q2 2025 and $26.9 million in Q1 2025.